Bcl-2, Bcl-xL, and P-AKT Are Involved in Neuroprotective Effects of Transcription Factor Brn3b in an Ocular Hypertension Rat Model of Glaucoma

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2016 Sep 3

PMID 27587945

Citations 15

Authors

Nitasha R Phatak

Dorota L Stankowska

Raghu R Krishnamoorthy

Affiliations

Soon will be listed here.

Abstract

Purpose: Brn3b is a class IV POU domain transcription factor that plays an important role in the development of retinal ganglion cells (RGCs), RGC survival, and particularly axon growth and pathfinding. Our previous study demonstrated that recombinant adenoassociated virus serotype 2 (rAAV-2)-mediated overexpression of Brn3b in RGCs promoted neuroprotection in a rodent model of glaucoma. However, the mechanisms underlying neuroprotection of RGCs in rats overexpressing Brn3b in animal models of glaucoma remain largely unknown. The goal of this study was to understand some of the mechanisms underlying the neuroprotection of RGCs overexpressing Brn3b during intraocular pressure (IOP) elevation in Brown Norway rats.

Methods: One eye of Brown Norway rats (Rattus norvegicus) was injected with an AAV construct encoding either green fluorescent protein (GFP; recombinant adenoassociated virus-green fluorescent protein, rAAV-hSyn-GFP) or Brn3b (rAAV-hSyn-Brn3b). Expression of antiapoptotic proteins, including B cell lymphoma/leukemia-2 (Bcl-2) family proteins (Bcl-2 and Bcl-xL), and p-AKT, was observed following immunostaining of rat retinas that overexpress Brn3b. In a different set of experiments, intraocular pressure was elevated in one eye of Brown Norway rats, which was followed by intravitreal injection with AAV constructs encoding either GFP (rAAV-CMV-GFP) or Brn3b (rAAV-CMV-Brn3b). Retinal sections were stained for prosurvival factors, including Bcl-2, Bcl-XL, and p-AKT.

Results: AAV-mediated expression of transcription factor Brn3b promoted statistically significant upregulation of the Bcl-2 protein and increased expression of p-AKT in RGCs of Brown Norway rats. In addition, following IOP elevation, AAV-mediated Brn3b expression also statistically significantly increased levels of Bcl-2 in the RGC layer in Brown Norway rats.

Conclusions: Adenoassociated virus-mediated Brn3b protein overexpression may promote neuroprotection by upregulating key antiapoptotic proteins, including Bcl-2, Bcl-xL, and p-AKT, in animal models of glaucoma.

Citing Articles

Protective effect of resveratrol on retinal damage in glaucoma: a systematic review and meta-analysis of preclinical studies.

Zhang F, Li T, Wan J, Wang L, Guo W, Hu Y Front Pharmacol. 2025; 15:1521188.

PMID: 39881870 PMC: 11774946. DOI: 10.3389/fphar.2024.1521188.

Emerging strategies targeting genes and cells in glaucoma.

Roy S Vision Res. 2024; 227:108533.

PMID: 39644708 PMC: 11788065. DOI: 10.1016/j.visres.2024.108533.

The broad-spectrum deubiquitinating enzyme inhibitor PR-619 protects retinal ganglion cell and augments parkin-mediated mitophagy in experimental glaucoma.

Hu X, Zhang J, Ma H, Lian W, Song W, Du C Sci Rep. 2024; 14(1):24654.

PMID: 39428410 PMC: 11491476. DOI: 10.1038/s41598-024-75562-3.

AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?.

Castro B, Steel J, Layton C Expert Rev Mol Med. 2024; 26:e9.

PMID: 38618935 PMC: 11062146. DOI: 10.1017/erm.2024.4.

Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma.

Starr C, Chen B Vision Res. 2023; 206:108196.

PMID: 36812679 PMC: 10085843. DOI: 10.1016/j.visres.2023.108196.

References

Quigley H, Addicks E, Green W, MAUMENEE A . Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981; 99(4):635-49. DOI: 10.1001/archopht.1981.03930010635009. View

Cenni M, Bonfanti L, Martinou J, Ratto G, Strettoi E, Maffei L . Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice. Eur J Neurosci. 1996; 8(8):1735-45. DOI: 10.1111/j.1460-9568.1996.tb01317.x. View

Burgering B, Coffer P . Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995; 376(6541):599-602. DOI: 10.1038/376599a0. View

Tsai R, Chang C, Sheu M, Huang Z . Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp Eye Res. 2010; 90(5):537-45. DOI: 10.1016/j.exer.2010.01.004. View

Nickells R, Semaan S, Schlamp C . Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog Brain Res. 2008; 173:423-35. DOI: 10.1016/S0079-6123(08)01129-1. View

Erkman L, McEvilly R, Luo L, Ryan A, Hooshmand F, OConnell S . Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature. 1996; 381(6583):603-6. DOI: 10.1038/381603a0. View

Nakazawa T, Shimura M, Tomita H, Akiyama H, Yoshioka Y, Kudou H . Intrinsic activation of PI3K/Akt signaling pathway and its neuroprotective effect against retinal injury. Curr Eye Res. 2003; 26(1):55-63. DOI: 10.1076/ceyr.26.1.55.14254. View

Quigley H, Addicks E . Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981; 99(1):137-43. DOI: 10.1001/archopht.1981.03930010139020. View

Gan L, Wang S, Huang Z, Klein W . POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev Biol. 1999; 210(2):469-80. DOI: 10.1006/dbio.1999.9280. View

10.

Cioffi G . Care guidelines and optic nerve assessment. J Glaucoma. 1996; 5(1):A12. View

11.

Chaudhary P, Ahmed F, Quebada P, Sharma S . Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res Mol Brain Res. 1999; 67(1):36-45. DOI: 10.1016/s0169-328x(99)00032-7. View

12.

Xiang M, Gan L, Li D, Zhou L, Chen Z, Wagner D . Role of the Brn-3 family of POU-domain genes in the development of the auditory/vestibular, somatosensory, and visual systems. Cold Spring Harb Symp Quant Biol. 1997; 62:325-36. View

13.

Franke T, Kaplan D, Cantley L . PI3K: downstream AKTion blocks apoptosis. Cell. 1997; 88(4):435-7. DOI: 10.1016/s0092-8674(00)81883-8. View

14.

Luo J, Cen L, Zhang X, Chiang S, Huang Y, Lin D . PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur J Neurosci. 2007; 26(4):828-42. DOI: 10.1111/j.1460-9568.2007.05718.x. View

15.

Xiang M, Zhou L, Nathans J . Similarities and differences among inner retinal neurons revealed by the expression of reporter transgenes controlled by Brn-3a, Brn-3b, and Brn-3c promotor sequences. Vis Neurosci. 1996; 13(5):955-62. DOI: 10.1017/s0952523800009184. View

16.

Hayreh S . Posterior ciliary arterial occlusive disorders. Trans Ophthalmol Soc U K (1962). 1971; 91:291-303. View

17.

Ewings K, Wiggins C, Cook S . Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle. 2007; 6(18):2236-40. DOI: 10.4161/cc.6.18.4728. View

18.

Quigley H . Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995; 23(2):85-91. DOI: 10.1111/j.1442-9071.1995.tb00135.x. View

19.

Camp A, Ruggeri M, Munguba G, Tapia M, John S, Bhattacharya S . Structural correlation between the nerve fiber layer and retinal ganglion cell loss in mice with targeted disruption of the Brn3b gene. Invest Ophthalmol Vis Sci. 2011; 52(8):5226-32. PMC: 3176044. DOI: 10.1167/iovs.10-6307. View

20.

Chierzi S, Cenni M, Maffei L, Pizzorusso T, Porciatti V, Ratto G . Protection of retinal ganglion cells and preservation of function after optic nerve lesion in bcl-2 transgenic mice. Vision Res. 1998; 38(10):1537-43. DOI: 10.1016/s0042-6989(97)00332-5. View